These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 34524435)

  • 1. Analysis of State Cannabis Laws and Dispensary Staff Recommendations to Adults Purchasing Medical Cannabis.
    Merlin JS; Althouse A; Feldman R; Arnsten JH; Bulls HW; Liebschutz JM; Nugent SM; Orris SR; Rohac R; Starrels JL; Morasco BJ; Kansagara D
    JAMA Netw Open; 2021 Sep; 4(9):e2124511. PubMed ID: 34524435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cannabis dispensary staff approaches to counseling on potential contraindications to cannabis use: insights from a national self-report survey.
    Slawek DE; Althouse AD; Feldman R; Arnsten JH; Bulls HW; Liebschutz JM; Nugent SM; Orris SR; Rohac R; Starrels JL; Morasco BJ; Kansagara D; Merlin JS
    BMC Prim Care; 2023 Jul; 24(1):145. PubMed ID: 37442944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dispensary Staff Perceptions About the Benefits, Risks, and Safety of Cannabis for Medical Purposes.
    Bulls HW; Althouse AD; Feldman R; Arnsten JH; Liebschutz JM; Nugent SM; Orris SR; Rohac R; Slawek DE; Starrels JL; Morasco BJ; Kansagara D; Merlin JS
    Subst Abus; 2023 Jul; 44(3):226-234. PubMed ID: 37706479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of Cannabis to Relieve Pain and Promote Sleep by Customers at an Adult Use Dispensary.
    Bachhuber M; Arnsten JH; Wurm G
    J Psychoactive Drugs; 2019; 51(5):400-404. PubMed ID: 31264536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of State Policies Allowing Medical Cannabis for Opioid Use Disorder With Dispensary Marketing for This Indication.
    Shover CL; Vest NA; Chen D; Stueber A; Falasinnu TO; Hah JM; Kim J; Mackey I; Weber KA; Ziadni M; Humphreys K
    JAMA Netw Open; 2020 Jul; 3(7):e2010001. PubMed ID: 32662844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prices and Purchase Sources for Dried Cannabis Flower in the United States, 2019-2020.
    Wadsworth E; Driezen P; Pacula RL; Kilmer B; Hammond D
    Cannabis Cannabinoid Res; 2023 Oct; 8(5):923-932. PubMed ID: 35363550
    [No Abstract]   [Full Text] [Related]  

  • 7. Training and Practices of Cannabis Dispensary Staff.
    Haug NA; Kieschnick D; Sottile JE; Babson KA; Vandrey R; Bonn-Miller MO
    Cannabis Cannabinoid Res; 2016; 1(1):244-251. PubMed ID: 28861496
    [No Abstract]   [Full Text] [Related]  

  • 8. Development and Pilot Testing of an Experimental Cannabis Marketplace: Toward Evaluating the Impact of Cannabis Policy on Consumer Choices.
    Coughlin LN; Jennings CJ; Hellman L; Florimbio AR; Jannausch M; Bonar EE
    Cannabis Cannabinoid Res; 2024 Jun; 9(3):e870-e877. PubMed ID: 37347989
    [No Abstract]   [Full Text] [Related]  

  • 9. Recommendations From Cannabis Dispensaries About First-Trimester Cannabis Use.
    Dickson B; Mansfield C; Guiahi M; Allshouse AA; Borgelt LM; Sheeder J; Silver RM; Metz TD
    Obstet Gynecol; 2018 Jun; 131(6):1031-1038. PubMed ID: 29742676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perceptions of Marijuana Use for Glaucoma from Patients, Cannabis Retailers, and Glaucoma Specialists.
    Weldy EW; Stanley J; Koduri VA; McCourt EA; Patnaik JL; Kahook MY; Seibold LK
    Ophthalmol Glaucoma; 2020; 3(6):453-459. PubMed ID: 32782211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survey of Pharmacists' Knowledge of Connecticut's Medical Cannabis Program.
    Reece SM; Holle L; Mukherjee K
    Cannabis Cannabinoid Res; 2021; 6(1):66-73. PubMed ID: 33614954
    [No Abstract]   [Full Text] [Related]  

  • 12. Backgrounds and Trainings in Cannabis Therapeutics of Dispensary Personnel.
    Braun IM; Nayak MM; Roberts JE; Chai PR; Tulsky JA; Abrams DI; Pirl W
    JCO Oncol Pract; 2022 Nov; 18(11):e1787-e1795. PubMed ID: 35969815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How medical are states' medical cannabis policies?: Proposing a standardized scale.
    Richard EL; Althouse AD; Arnsten JH; Bulls HW; Kansagara D; Kerbag MN; Lichius C; Lipsey D; Morasco BJ; Nugent SM; Merlin JS; Starrels JL
    Int J Drug Policy; 2021 Aug; 94():103202. PubMed ID: 33765514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between county level cannabis dispensary counts and opioid related mortality rates in the United States: panel data study.
    Hsu G; Kovács B
    BMJ; 2021 Jan; 372():m4957. PubMed ID: 33504472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mapping cannabis potency in medical and recreational programs in the United States.
    Cash MC; Cunnane K; Fan C; Romero-Sandoval EA
    PLoS One; 2020; 15(3):e0230167. PubMed ID: 32214334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concerns of Patients With Cancer on Accessing Cannabis Products in a State With Restrictive Medical Marijuana Laws: A Survey Study.
    Singh V; Zarrabi AJ; Curseen KA; Sniecinski R; Welsh JW; McKenzie-Brown AM; Baer W; Gillespie TW
    J Oncol Pract; 2019 Oct; 15(10):531-538. PubMed ID: 31442099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlates of Amount Spent on Marijuana Buds During a Discrete Purchase at Medical Marijuana Dispensaries: Results from a Pilot Study.
    Kepple NJ; Mulholland E; Freisthler B; Schaper E
    J Psychoactive Drugs; 2016; 48(1):50-5. PubMed ID: 26757234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An Observational Cross-Sectional Survey Exploring the Indications for and Responses to Medical Marijuana Use in Certified Patients in Pennsylvania.
    Kimless D; Caloura M; Markos V; Ryan J; Abbonizio S; Janicki S
    J Prim Care Community Health; 2022; 13():21501319221129734. PubMed ID: 36226444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An examination of cannabis-related information typically asked by consumers at retail cannabis locations: A Canadian survey of budtenders and managers.
    Cameron J; Dhalla R; Lougheed T; Blanc A; Vaillancourt R
    Can Pharm J (Ott); 2023; 156(3):150-158. PubMed ID: 37201171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cannabis Retail Staff ("Budtenders") Attitudes Towards Cannabis Effects on Health and Experiences Interacting with Consumers - Washington State, USA.
    Carlini BH; Garrett SB; Firth C; Harwick R
    J Psychoactive Drugs; 2022; 54(1):34-42. PubMed ID: 33781175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.